Last mentioned: Mar 4, 2026
Product Expansion
Expected rollout of next-generation software updates for handheld mass spectrometry devices.
Earnings Calls
Management teams from MASS and SRTA host simultaneous investor calls to discuss 2026 guidance.
SEC Filings
908 Devices and Strata Critical Medical file 8-K reports detailing Q4 and full-year 2025 financial results.
908 Devices Inc. and Strata Critical Medical reported Q4 2025 results, highlighting a strategic pivot toward decentralized diagnostics and bioprocessing efficiency. Both companies emphasized recurring revenue growth from consumables as they navigate a complex capital equipment environment.
This page surfaces every story mentioning 908 Devices Inc. across our finance coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running finance beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where 908 Devices Inc. was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |